Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3476328 | 0.91 | GAA (0.36) | GAAHTTSMN1; SMN2KCNH2CYP2C19 | |
| SCHEMBL3646931 | 0.81 | GAA (0.39) | GAAHTTSMN1; SMN2KCNH2CYP2C19 | |
| SCHEMBL460099 | 0.73 | L3MBTL1 (0.37) | GAAHTTSMN1; SMN2ATM | |
| SCHEMBL23510052 | 0.71 | GAA (0.35) | GAAHTTSMN1; SMN2CYP2C19ATM | |
| SCHEMBL2470414 | 0.70 | GAA (0.35) | GAAHTTSMN1; SMN2KCNH2ATM | |
| SCHEMBL3121971 | 0.69 | GAA (0.45) | GAAHTTSMN1; SMN2ATM | |
| SCHEMBL3125386 | 0.69 | GAA (0.45) | GAAHTTSMN1; SMN2ATM | |
| SCHEMBL3135629 | 0.69 | GAA (0.45) | GAAHTTSMN1; SMN2ATM | |
| SCHEMBL174682 | 0.69 | GAA (0.45) | GAAHTTSMN1; SMN2ATM | |
| SCHEMBL3132086 | 0.69 | GAA (0.45) | GAAHTTSMN1; SMN2ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020206518-A1 | MULTIPURPOSE BIOLOGICAL COMPOSITIONS | AGRIVALLE BRASIL INDUSTRIA E COMÉRCIO DE PRODUTOS AGRÍCOLAS LTDA (BR) | 2020-10-15 | — | — | WO | claimed |
| EP-2611296-A2 | FUNGICIDAL PYRAZOLES AND THEIR MIXTURES | E.I. Du Pont De Nemours And Company (US) | 2013-07-10 | — | — | EP | claimed |
| WO-2012031061-A2 | FUNGICIDAL PYRAZOLES AND THEIR MIXTURES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-03-08 | — | — | WO | claimed |
| WO-2011056463-A2 | FUNGICIDAL MIXTURES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-05-12 | — | — | WO | claimed |
| US-20100093715-A1 | Plant productivity enhancement by combining chemical agents with transgenic modifications | BASF SE (DE) | 2010-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100093715-A1 | Plant productivity enhancement by combining chemical agents with transgenic modifications | CBR3, MYB, HACL2 | GAA 703/4885HTT 2649/4885SMN1; SMN2 4806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.